- Home
- SCOR vs LSTA Comparison
SCOR vs LSTA Comparison
Compare SCOR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCOR
- LSTA
- Stock Information
- Founded
- SCOR 1999
- LSTA 1980
- Country
- SCOR United States
- LSTA United States
- Employees
- SCOR N/A
- LSTA 26
- Industry
- SCOR Business Services
- LSTA Misc Health and Biotechnology Services
- Sector
- SCOR Consumer Discretionary
- LSTA Health Care
- Exchange
- SCOR Nasdaq
- LSTA Nasdaq
- Market Cap
- SCOR 23.9M
- LSTA 22.5M
- IPO Year
- SCOR 2007
- LSTA N/A
- Fundamental
- Price
- SCOR $5.84
- LSTA $2.72
- Analyst Decision
- SCOR Buy
- LSTA Strong Buy
- Analyst Count
- SCOR 2
- LSTA 1
- Target Price
- SCOR $10.75
- LSTA $15.00
- AVG Volume (30 Days)
- SCOR 22.6K
- LSTA 23.4K
- Earning Date
- SCOR 08-05-2025
- LSTA 08-11-2025
- Dividend Yield
- SCOR N/A
- LSTA N/A
- EPS Growth
- SCOR N/A
- LSTA N/A
- EPS
- SCOR N/A
- LSTA N/A
- Revenue
- SCOR $354,961,000.00
- LSTA $1,000,000.00
- Revenue This Year
- SCOR $3.36
- LSTA N/A
- Revenue Next Year
- SCOR $2.72
- LSTA N/A
- P/E Ratio
- SCOR N/A
- LSTA N/A
- Revenue Growth
- SCOR N/A
- LSTA N/A
- 52 Week Low
- SCOR $4.39
- LSTA $1.87
- 52 Week High
- SCOR $15.31
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- SCOR 66.75
- LSTA 52.43
- Support Level
- SCOR $4.39
- LSTA $2.34
- Resistance Level
- SCOR $5.34
- LSTA $3.09
- Average True Range (ATR)
- SCOR 0.32
- LSTA 0.25
- MACD
- SCOR 0.09
- LSTA 0.01
- Stochastic Oscillator
- SCOR 99.57
- LSTA 50.67
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.